Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003)

Keijiro Sugimura(Osaka International Cancer Institute), Yuichiro� Doki(Osaka Gakuin University), Masahiko Yano(Nagoya Sangyo University), Masaaki Motoori(Osaka International Cancer Institute), Hiroshi Miyata(Osaka University), Makoto Yamasaki(The University of Osaka), Koji Tanaka(Mie University), Osamu Shiraishi(Kindai University), Kazumasa Fujitani(Osaka Prefectural Medical Center), Tomoki Makino(The University of Osaka), Yutaka Kimura(Kansai Medical University), Takushi Yasuda(Osaka International Cancer Institute), Motohiro Hirao(Osaka National Hospital), Masaki Mori(Tokai University), Takayuki Kii(Osaka Medical and Pharmaceutical University), Taro Satoh(The University of Osaka), Atsushi Takeno(Kansai Rosai Hospital)
Annals of Gastroenterological Surgery
November 28, 2020
Cited by 27


Related Papers